This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting gastrointestinal disorders, particularly those involving acid-related conditions. Its structural features, including the difluoromethoxy and dimethoxypyridine groups, contribute to its efficacy in modulating biological pathways. Additionally, it is explored for its potential in designing novel therapeutic agents with improved bioavailability and reduced side effects. Researchers also investigate its application in creating compounds with anti-inflammatory and anti-ulcer properties, making it valuable in medicinal chemistry.